IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial Advertise
 

Search About Journals, Conferences, and Book Series


Frontiers in Clinical Drug Research - Alzheimer Disorders- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on November 16, 2021

Impact Score

0.71

h-Index

 2

Rank

 17269

SJR

 0.238

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Frontiers in Clinical Drug Research - Alzheimer Disorders
Abbreviation Front. Clin. Drug Res. - Alzheimer Disord.
Publication Type Book series
Subject Area, Categories, Scope Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3); Neurology (clinical) (Q4)
h-index 2
Overall Rank/Ranking 17269
SCImago Journal Rank (SJR) 0.238
Impact Score 0.71
Publisher Bentham Science Publishers B.V.
Country Netherlands
ISSN 22145168, 24518743




About Frontiers in Clinical Drug Research - Alzheimer Disorders


Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3); Neurology (clinical) (Q4). It is published by Bentham Science Publishers B.V.. The overall rank of Frontiers in Clinical Drug Research - Alzheimer Disorders is 17269. According to SCImago Journal Rank (SJR), this book series is ranked 0.238. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 2. The best quartile for this book series is Q3.

The ISSN of Frontiers in Clinical Drug Research - Alzheimer Disorders book series is 22145168, 24518743. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Frontiers in Clinical Drug Research - Alzheimer Disorders is cited by a total of 5 articles during the last 3 years (Preceding 2020).


Frontiers in Clinical Drug Research - Alzheimer Disorders Impact Score 2020-2021


The impact score (IS) 2020 of Frontiers in Clinical Drug Research - Alzheimer Disorders is 0.71, which is computed in 2021 as per its definition. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Trend


Year wise Impact Score (IS) of Frontiers in Clinical Drug Research - Alzheimer Disorders. Based on Scopus data.


Year Impact Score (IS)
2021/2022 Coming Soon
2020 0.71
2019 0.00
2018 ''
2017 ''
2016 ''
2015 ''
2014 ''

Frontiers in Clinical Drug Research - Alzheimer Disorders h-index


  Table Setting

Frontiers in Clinical Drug Research - Alzheimer Disorders has an h-index of 2. It means 2 articles of this book series have more than 2 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Frontiers in Clinical Drug Research - Alzheimer Disorders ISSN


The ISSN of Frontiers in Clinical Drug Research - Alzheimer Disorders is 22145168, 24518743. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Frontiers in Clinical Drug Research - Alzheimer Disorders Rank and SCImago Journal Rank (SJR)


The overall rank of Frontiers in Clinical Drug Research - Alzheimer Disorders is 17269. According to SCImago Journal Rank (SJR), this book series is ranked 0.238. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Frontiers in Clinical Drug Research - Alzheimer Disorders Publisher


Table Setting

Frontiers in Clinical Drug Research - Alzheimer Disorders is published by Bentham Science Publishers B.V.. It's publishing house is located in Netherlands. Coverage history of this book series is as following: 2019. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Frontiers in Clinical Drug Research - Alzheimer Disorders is Front. Clin. Drug Res. - Alzheimer Disord.. This abbreviation ('Front. Clin. Drug Res. - Alzheimer Disord.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Frontiers in Clinical Drug Research - Alzheimer Disorders


If your research field is/are related to Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3); Neurology (clinical) (Q4), then please visit the official website of this book series.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
International Journal of Structural Integrity journal 18781 Emerald Group Publishing Ltd. 19 0.60
Electronic Journal of Combinatorics journal 7077 Electronic Journal of Combinatorics 52 1.28
2019 IEEE International Conference on Networking, Architecture and Storage, NAS 2019 - Proceedings conference and proceedings 29824 1 0.18
Indian Geotechnical Journal journal 10869 Springer India 15 1.39
Contemporary Perspectives in Family Research book series 30568 Emerald Group Publishing Ltd. 9 0.57
Baltic Journal of Coleopterology journal 11802 Baltic Institute of Coleopterology 14 0.40
Asian ESP Journal journal 14166 Asian EFL Journal Press 9 1.03
Australian Journal of Management journal 11659 SAGE Publications Ltd 39 2.06
Journal of Telecommunications and Information Technology journal 23080 National Institute of Telecommunications 12 0.79
International Journal of Computer Network and Information Security journal 32744 Modern Education and Computer Science Press 1 0.00

Check complete list




Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier | Netherlands

Advanced Drug Delivery Reviews
Elsevier | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Journal of Controlled Release
Elsevier | Netherlands

Journal of Nanobiotechnology
BioMed Central Ltd. | United Kingdom

Apoptosis : an international journal on programmed cell death
Springer Netherlands | Netherlands

Pharmaceuticals
MDPI Multidisciplinary Digital Publishing Institute | Switzerland

Bioconjugate Chemistry
American Chemical Society | United States

Nanomedicine: Nanotechnology, Biology, and Medicine
Elsevier Inc. | United States

International Journal of Nanomedicine
Dove Medical Press Ltd. | New Zealand

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

See All

Top Journals/Conferences in Psychiatry and Mental Health

World Psychiatry
Wiley-Blackwell | United States

Annual Review of Clinical Psychology
Annual Reviews Inc. | United States

JAMA Psychiatry
American Medical Association | United States

Lancet Psychiatry,The
Elsevier Ltd. | United Kingdom

Alzheimer's and Dementia
Elsevier Inc. | United States

Clinical Psychology Review
Elsevier Inc. | United States

American Journal of Psychiatry
American Psychiatric Association | United States

Molecular Psychiatry
Nature Publishing Group | United Kingdom

Schizophrenia Bulletin
Oxford University Press | United Kingdom

Journal of Abnormal Psychology
American Psychological Association Inc. | United States

See All

Top Journals/Conferences in Neurology (clinical)

Lancet Neurology, The
Lancet Publishing Group | United Kingdom

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Alzheimer's and Dementia
Elsevier Inc. | United States

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

JAMA Neurology
American Medical Association | United States

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley and Sons Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All